Dr. Congdon's experience with the Global Health track illustrates how each of the five pillars adopted by the Pediatrics Residency Program helps to create a meaningful rotation experience.

CHOP physicians find baby monitors that use pulse oximetry technology have concerning problems with accuracy.

The grand opening of CHOP’s new Clinical Manufacturing Facility highlights its role in manufacturing tools for 21st century precision medicine, to bring innovative treatments to patients.

Two CHOP researchers were on a team that proposes potential ways to avoid future infertility in boys who are treated with chemotherapy and radiation for childhood cancer.

Blocking disease-causing biological signals may lead to a new treatment for the life-threatening childhood blood disorder Fanconi anemia.

Recent research has discovered a new genetic cause for a severe, difficult-to-treat childhood epilepsy syndrome, and found clues to potential medical treatments.

Research findings may shed light into possible mechanisms underlying the increased obesity risk in children with ASD, which may offer targets for early intervention.

CHOP researcher Dr. John Wolfe is working to manipulate stem cells to restore vision in genetic cases of blindness, under a new $6.9 million federal grant.

For 10 years, PolicyLab focused its research on those with lower socio-economic status, in underserved areas and with chronic conditions.

Some diseases affect only a small number of people, and yet CHOP’s commitment to researching and treating them is huge.